KMICB - Rifaximin (shared care guidance)
KMICB Rifaximin for the treatment of Hepatic Encephalopathy (HE) SCP June 2025 V1
KMICB Rifaximin Shared Care Request Letter
KMICB Rifaximin Shared Care Agreement Letter
KMICB Rifaximin Shared Care Refusal Letter
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary